The Clinical Department of Hematology and Hemostaseology at MedUni
Vienna at Vienna General Hospital primarily wants to make the
innovations discovered in laboratory and preclinical research
available to patients as soon as possible for diagnostics and
therapy ("translational research").
The division is structured into program directorates for laboratory and clinical research. Internationally recognized experts lead these programs, which benefit patients. On the other hand, we offer our patients the opportunity to participate in study programs.
The Division of Haematology and Haemostaseology is also part of the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital and participates in numerous clinical programs and research collaborations, including the Ludwig Boltzmann Institute of Haematology and Oncology (Head: Univ.-Prof. Dr. Peter Valent).
Program/Research Focus:
Hematology
Hemostaseology
The field of Haemostaseology is represented by internationally renowned clinically and scientifically practicing physicians and is additionally strengthened by two chairs (Univ.-Prof.in Dr.in med.univ. Sabine Eichinger-Hasenauer, Univ.-Prof. Priv.-Doz. Dr. Cihan Ay) in science and teaching.
The research focuses on the entire spectrum of congenital and acquired thrombosis and hemostasis disorders, including thrombocytopenia and antithrombotic therapies.
The Department is a "European Haemophilia Comprehensive Care Center" recognized by the European Association for Haemophilia and Allied Disorders (EAHAD) and is an "International Hemophilia Training Center" designated by the World Federation of Hemophilia (WFH).